GPCR dynamics: Structures in motion

Chemical Reviews

Volumn 117, Issue 1, 2017, Pages 139-155

  Latorraca, Naomi R ^a,b   Venkatakrishnan, A J ^a,b   Dror, Ron O ^a,b,c  

^a Department of Computer Science ^*  (United States)

^b Biophysics Program   (United States)

^c Stanford University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINS; STRUCTURAL DYNAMICS;

ALLOSTERIC MODULATION; CONFORMATIONAL PLASTICITY; DRUG DESIGN; DRUG TARGETS; G PROTEIN COUPLED RECEPTORS; LIGAND BINDING; MEMBRANE PROTEINS; RATIONAL DESIGN;

DYNAMICS;

G PROTEIN COUPLED RECEPTOR;

CHEMISTRY; PROTEIN CONFORMATION;

PROTEIN CONFORMATION; RECEPTORS, G-PROTEIN-COUPLED;

EID: 85021857088     PISSN: 00092665     EISSN: 15206890     Source Type: Journal    
DOI: 10.1021/acs.chemrev.6b00177     Document Type: Review

References (159)

1. Rosenbaum, D. M.; Cherezov, V.; Hanson, M. A.; Rasmussen, S. G.; Thian, F. S.; Kobilka, T. S.; Choi, H. J.; Yao, X. J.; Weis, W. I.; Stevens, R. C.; et al. GPCR Engineering Yields High-Resolution Structural Insights into Beta2-Adrenergic Receptor Function. Science 2007, 318, 1266-1273.
2. Rasmussen, S. G.; Choi, H. J.; Fung, J. J.; Pardon, E.; Casarosa, P.; Chae, P. S.; Devree, B. T.; Rosenbaum, D. M.; Thian, F. S.; Kobilka, T. S.; et al. Structure of a Nanobody-Stabilized Active State of the Beta(2) Adrenoceptor. Nature 2011, 469, 175-180.
3. Rasmussen, S. G.; DeVree, B. T.; Zou, Y.; Kruse, A. C.; Chung, K. Y.; Kobilka, T. S.; Thian, F. S.; Chae, P. S.; Pardon, E.; Calinski, D.; et al. Crystal Structure of the Beta2 Adrenergic Receptor-Gs Protein Complex. Nature 2011, 477, 549-555.
4. Warne, T.; Serrano-Vega, M. J.; Baker, J. G.; Moukhametzianov, R.; Edwards, P. C.; Henderson, R.; Leslie, A. G.; Tate, C. G.; Schertler, G. F. Structure of a Beta1-Adrenergic G-Protein-Coupled Receptor. Nature 2008, 454, 486-491.
5. Venkatakrishnan, A. J.; Deupi, X.; Lebon, G.; Tate, C. G.; Schertler, G. F.; Babu, M. M. Molecular Signatures of G-Protein-Coupled Receptors. Nature 2013, 494, 185-194.
6. Isberg, V.; Mordalski, S.; Munk, C.; Rataj, K.; Harpsoe, K.; Hauser, A. S.; Vroling, B.; Bojarski, A. J.; Vriend, G.; Gloriam, D. E. GPCRdb: An Information System for G Protein-Coupled Receptors. Nucleic Acids Res. 2016, 44, D356-D364.
7. GPCRdb: An Information System for G Protein-Coupled Receptors. http://gpcrdb.org/structure/statistics, accessed July 18, 2016.
8. Adcock, S. A.; McCammon, J. A. Molecular Dynamics: Survey of Methods for Simulating the Activity of Proteins. Chem. Rev. 2006, 106, 1589-1615.
9. Rosenbaum, D. M.; Rasmussen, S. G.; Kobilka, B. K. The Structure and Function of G-Protein-Coupled Receptors. Nature 2009, 459, 356-363.
10. Fredriksson, R.; Lagerstrom, M. C.; Lundin, L.-G.; Schioth, H. B. The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints. Mol. Pharmacol. 2003, 63, 1256-1272.
11. Lagerstrom, M. C.; Schioth, H. B. Structural Diversity of G Protein-Coupled Receptors and Significance for Drug Discovery. Nat. Rev. Drug Discovery 2008, 7, 339-357.
12. Henzler-Wildman, K.; Kern, D. Dynamic Personalities of Proteins. Nature 2007, 450, 964-972.
13. Granier, S.; Kobilka, B. A New Era of GPCR Structural and Chemical Biology. Nat. Chem. Biol. 2012, 8, 670-673.
14. Wishart, D. S. Interpreting Protein Chemical Shift Data. Prog. Nucl. Magn. Reson. Spectrosc. 2011, 58, 62-87.
15. Jeschke, G. DEER Distance Measurements on Proteins. Annu. Rev. Phys. Chem. 2012, 63, 419-446.
16. Lohse, M. J.; Hein, P.; Hoffmann, C.; Nikolaev, V. O.; Vilardaga, J. P.; Bunemann, M. Kinetics of G-Protein-Coupled Receptor Signals in Intact Cells. Br. J. Pharmacol. 2008, 153 (S1), S125-S132.
17. Lohse, M. J.; Nuber, S.; Hoffmann, C. Fluorescence/Bioluminescence Resonance Energy Transfer Techniques to Study G-Protein-Coupled Receptor Activation and Signaling. Pharmacol. Rev. 2012, 64, 299-336.
18. Mansoor, S. E.; Dewitt, M. A.; Farrens, D. L. Distance Mapping in Proteins Using Fluorescence Spectroscopy: The Tryptophan-Induced Quenching (TrIQ) Method. Biochemistry 2010, 49, 9722-9731.
19. Park, S. H.; Das, B. B.; Casagrande, F.; Tian, Y.; Nothnagel, H. J.; Chu, M.; Kiefer, H.; Maier, K.; De Angelis, A. A.; Marassi, F. M.; et al. Structure of the Chemokine Receptor CXCR1 in Phospholipid Bilayers. Nature 2012, 491, 779-783.
20. Dror, R. O.; Dirks, R. M.; Grossman, J. P.; Xu, H.; Shaw, D. E. Biomolecular Simulation: A Computational Microscope for Molecular Biology. Annu. Rev. Biophys. 2012, 41, 429-452.
21. Dror, R. O.; Arlow, D. H.; Borhani, D. W.; Jensen, M. O.; Piana, S.; Shaw, D. E. Identification of Two Distinct Inactive Conformations of the Beta2-Adrenergic Receptor Reconciles Structural and Biochemical Observations. Proc. Natl. Acad. Sci. U. S. A. 2009, 106, 4689-4694.
22. Nygaard, R.; Zou, Y.; Dror, R. O.; Mildorf, T. J.; Arlow, D. H.; Manglik, A.; Pan, A. C.; Liu, C. W.; Fung, J. J.; Bokoch, M. P.; et al. The Dynamic Process of Beta(2)-Adrenergic Receptor Activation. Cell 2013, 152, 532-542.
23. Dror, R. O.; Arlow, D. H.; Maragakis, P.; Mildorf, T. J.; Pan, A. C.; Xu, H.; Borhani, D. W.; Shaw, D. E. Activation Mechanism of the Beta2-Adrenergic Receptor. Proc. Natl. Acad. Sci. U. S. A. 2011, 108, 18684-18689.
24. Manglik, A.; Kim, T. H.; Masureel, M.; Altenbach, C.; Yang, Z.; Hilger, D.; Lerch, M. T.; Kobilka, T. S.; Thian, F. S.; Hubbell, W. L.; et al. Structural Insights into the Dynamic Process of Beta2-Adrenergic Receptor Signaling. Cell 2015, 161, 1101-1111.
25. Kobilka, B. K.; Deupi, X. Conformational Complexity of GProtein-Coupled Receptors. Trends Pharmacol. Sci. 2007, 28, 397-406.
26. Xue, L.; Rovira, X.; Scholler, P.; Zhao, H.; Liu, J.; Pin, J. P.; Rondard, P. Major Ligand-Induced Rearrangement of the Heptahelical Domain Interface in a GPCR Dimer. Nat. Chem. Biol. 2015, 11, 134-140.
27. Tobin, A. B. G-Protein-Coupled Receptor Phosphorylation: Where, When and by Whom. Br. J. Pharmacol. 2008, 153 (S1), S167-S176.
28. Ranganathan, A.; Dror, R. O.; Carlsson, J. Insights into the Role of Asp79(2.50) in Beta2 Adrenergic Receptor Activation from Molecular Dynamics Simulations. Biochemistry 2014, 53, 7283-7296.
29. Dawaliby, R.; Trubbia, C.; Delporte, C.; Masureel, M.; Van Antwerpen, P.; Kobilka, B. K.; Govaerts, C. Allosteric Regulation of G Protein-Coupled Receptor Activity by Phospholipids. Nat. Chem. Biol. 2016, 12, 35-39.
30. Yohannan, S.; Faham, S.; Yang, D.; Whitelegge, J. P.; Bowie, J. U. The Evolution of Transmembrane Helix Kinks and the Structural Diversity of G Protein-Coupled Receptors. Proc. Natl. Acad. Sci. U. S. A. 2004, 101, 959-963.
31. Yuan, S.; Filipek, S.; Palczewski, K.; Vogel, H. Activation of GProtein-Coupled Receptors Correlates with the Formation of a Continuous Internal Water Pathway. Nat. Commun. 2014, 5, 4733.
32. Staus, D. P.; Strachan, R. T.; Manglik, A.; Pani, B.; Kahsai, A. W.; Kim, T. H.; Wingler, L. M.; Ahn, S.; Chatterjee, A.; Masoudi, A.; et Al. Allosteric Nanobodies Reveal the Dynamic Range and Diverse Mechanisms of G-Protein-Coupled Receptor Activation. Nature 2016, 535, 448.
33. Venkatakrishnan, A. J.; Flock, T.; Prado, D. E.; Oates, M. E.; Gough, J.; Madan Babu, M. Structured and Disordered Facets of the GPCR Fold. Curr. Opin. Struct. Biol. 2014, 27, 129-137.
34. Butcher, A. J.; Kong, K. C.; Prihandoko, R.; Tobin, A. B. Physiological Role of G-Protein Coupled Receptor Phosphorylation. Handb. Exp. Pharmacol. 2012, 208, 79-94.
35. Huang, W.; Manglik, A.; Venkatakrishnan, A. J.; Laeremans, T.; Feinberg, E. N.; Sanborn, A. L.; Kato, H. E.; Livingston, K. E.; Thorsen, T. S.; Kling, R. C.; et al. Structural Insights into Micro-Opioid Receptor Activation. Nature 2015, 524, 315-321.
36. Wheatley, M.; Wootten, D.; Conner, M. T.; Simms, J.; Kendrick, R.; Logan, R. T.; Poyner, D. R.; Barwell, J. Lifting the Lid on GPCRs: The Role of Extracellular Loops. Br. J. Pharmacol. 2012, 165, 1688-1703.
37. Wootten, D.; Christopoulos, A.; Sexton, P. M. Emerging Paradigms in GPCR Allostery: Implications for Drug Discovery. Nat. Rev. Drug Discovery 2013, 12, 630-644.
38. Dror, R. O.; Green, H. F.; Valant, C.; Borhani, D. W.; Valcourt, J. R.; Pan, A. C.; Arlow, D. H.; Canals, M.; Lane, J. R.; Rahmani, R.; et al. Structural Basis for Modulation of a G-Protein-Coupled Receptor by Allosteric Drugs. Nature 2013, 503, 295-299.
39. Kruse, A. C.; Ring, A. M.; Manglik, A.; Hu, J.; Hu, K.; Eitel, K.; Hubner, H.; Pardon, E.; Valant, C.; Sexton, P. M.; et al. Activation and Allosteric Modulation of a Muscarinic Acetylcholine Receptor. Nature 2013, 504, 101-106.
40. Ballesteros, J. A. W. H. Integrated Methods for the Construction of Three-Dimensional Models and Computational Probing of Structure-Function Relations in G Protein-Coupled Receptors. Methods Neurosci. 1995, 25, 366-428.
41. van der Westhuizen, E. T.; Valant, C.; Sexton, P. M.; Christopoulos, A. Endogenous Allosteric Modulators of G Protein-Coupled Receptors. J. Pharmacol. Exp. Ther. 2015, 353, 246-260.
42. DeVree, B. T.; Mahoney, J. P.; Velez-Ruiz, G. A.; Rasmussen, S. G.; Kuszak, A. J.; Edwald, E.; Fung, J. J.; Manglik, A.; Masureel, M.; Du, Y.; et al. Allosteric Coupling from G Protein to the Agonist-Binding Pocket in GPCRs. Nature 2016, 535, 182-186.
43. Kohlhoff, K. J.; Shukla, D.; Lawrenz, M.; Bowman, G. R.; Konerding, D. E.; Belov, D.; Altman, R. B.; Pande, V. S. Cloud-Based Simulations on Google Exacycle Reveal Ligand Modulation of GPCR Activation Pathways. Nat. Chem. 2014, 6, 15-21.
44. Katritch, V.; Cherezov, V.; Stevens, R. C. Structure-Function of the G Protein-Coupled Receptor Superfamily. Annu. Rev. Pharmacol. Toxicol. 2013, 53, 531-556.
45. Rosenbaum, D. M.; Zhang, C.; Lyons, J. A.; Holl, R.; Aragao, D.; Arlow, D. H.; Rasmussen, S. G.; Choi, H. J.; Devree, B. T.; Sunahara, R. K.; et al. Structure and Function of an Irreversible Agonist-Beta(2) Adrenoceptor Complex. Nature 2011, 469, 236-240.
46. Kruse, A. C.; Hu, J.; Pan, A. C.; Arlow, D. H.; Rosenbaum, D. M.; Rosemond, E.; Green, H. F.; Liu, T.; Chae, P. S.; Dror, R. O.; et al. Structure and Dynamics of the M3Muscarinic Acetylcholine Receptor. Nature 2012, 482, 552-556.
47. Manglik, A.; Kruse, A. C.; Kobilka, T. S.; Thian, F. S.; Mathiesen, J. M.; Sunahara, R. K.; Pardo, L.; Weis, W. I.; Kobilka, B. K.; Granier, S. Crystal Structure of the Micro-Opioid Receptor Bound to a Morphinan Antagonist. Nature 2012, 485, 321-326.
48. Venkatakrishnan, A. J.; Deupi, X.; Lebon, G.; Heydenreich, F. M.; Flock, T.; Miljus, T.; Balaji, S.; Bouvier, M.; Veprintsev, D. B.; Tate, C. G.; Schertler, G. F. X.; Babu, M. M. Diverse Activation Pathways in Class a GPCRs Converge near the G Protein-Coupling Region. Nature 2016, 536, 484-487.
49. Park, J. H.; Scheerer, P.; Hofmann, K. P.; Choe, H. W.; Ernst, O. P. Crystal Structure of the Ligand-Free G-Protein-Coupled Receptor Opsin. Nature 2008, 454, 183-187.
50. Blankenship, E.; Vahedi-Faridi, A.; Lodowski, D. T. The High-Resolution Structure of Activated Opsin Reveals a Conserved Solvent Network in the Transmembrane Region Essential for Activation. Structure 2015, 23, 2358-2364.
51. Granier, S.; Manglik, A.; Kruse, A. C.; Kobilka, T. S.; Thian, F. S.; Weis, W. I.; Kobilka, B. K. Structure of the Delta-Opioid Receptor Bound to Naltrindole. Nature 2012, 485, 400-404.
52. Lebon, G.; Warne, T.; Tate, C. G. Agonist-Bound Structures of G Protein-Coupled Receptors. Curr. Opin. Struct. Biol. 2012, 22, 482-490.
53. Isogai, S.; Deupi, X.; Opitz, C.; Heydenreich, F. M.; Tsai, C. J.; Brueckner, F.; Schertler, G. F.; Veprintsev, D. B.; Grzesiek, S. Backbone NMR Reveals Allosteric Signal Transduction Networks in the Beta1-Adrenergic Receptor. Nature 2016, 530, 237-241.
54. Sounier, R.; Mas, C.; Steyaert, J.; Laeremans, T.; Manglik, A.; Huang, W.; Kobilka, B. K.; Demene, H.; Granier, S. Propagation of Conformational Changes During Mu-Opioid Receptor Activation. Nature 2015, 524, 375-378.
55. Ye, L.; Van Eps, N.; Zimmer, M.; Ernst, O. P.; Prosser, R. S. Activation of the A2a Adenosine G-Protein-Coupled Receptor by Conformational Selection. Nature 2016, 533, 265-268.
56. Manglik, A.; Kobilka, B. The Role of Protein Dynamics in GPCR Function: Insights from the Beta2ar and Rhodopsin. Curr. Opin. Cell Biol. 2014, 27, 136-143.
57. Leioatts, N.; Romo, T. D.; Danial, S. A.; Grossfield, A. Retinal Conformation Changes Rhodopsin's Dynamic Ensemble. Biophys. J. 2015, 109, 608-617.
58. Ye, S.; Zaitseva, E.; Caltabiano, G.; Schertler, G. F.; Sakmar, T. P.; Deupi, X.; Vogel, R. Tracking G-Protein-Coupled Receptor Activation Using Genetically Encoded Infrared Probes. Nature 2010, 464, 1386-1389.
59. Altenbach, C.; Kusnetzow, A. K.; Ernst, O. P.; Hofmann, K. P.; Hubbell, W. L. High-Resolution Distance Mapping in Rhodopsin Reveals the Pattern of Helix Movement Due to Activation. Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 7439-7444.
60. Hofmann, K. P.; Scheerer, P.; Hildebrand, P. W.; Choe, H. W.; Park, J. H.; Heck, M.; Ernst, O. P. A G Protein-Coupled Receptor at Work: The Rhodopsin Model. Trends Biochem. Sci. 2009, 34, 540-552.
61. Violin, J. D.; Crombie, A. L.; Soergel, D. G.; Lark, M. W. Biased Ligands at G-Protein-Coupled Receptors: Promise and Progress. Trends Pharmacol. Sci. 2014, 35, 308-316.
62. Rajagopal, S.; Rajagopal, K.; Lefkowitz, R. J. Teaching Old Receptors New Tricks: Biasing Seven-Transmembrane Receptors. Nat. Rev. Drug Discovery 2010, 9, 373-386.
63. Romo, T. D.; Grossfield, A.; Pitman, M. C. Concerted Interconversion between Ionic Lock Substates of the Beta(2) Adrenergic Receptor Revealed by Microsecond Timescale Molecular Dynamics. Biophys. J. 2010, 98, 76-84.
64. Okada, T.; Fujiyoshi, Y.; Silow, M.; Navarro, J.; Landau, E. M.; Shichida, Y. Functional Role of Internal Water Molecules in Rhodopsin Revealed by X-Ray Crystallography. Proc. Natl. Acad. Sci. U. S. A. 2002, 99, 5982-5987.
65. Okada, T.; Sugihara, M.; Bondar, A. N.; Elstner, M.; Entel, P.; Buss, V. The Retinal Conformation and Its Environment in Rhodopsin in Light of a New 2.2 a Crystal Structure. J. Mol. Biol. 2004, 342, 571-583.
66. Li, J.; Edwards, P. C.; Burghammer, M.; Villa, C.; Schertler, G. F. Structure of Bovine Rhodopsin in a Trigonal Crystal Form. J. Mol. Biol. 2004, 343, 1409-1438.
67. Shapiro, D. A.; Kristiansen, K.; Weiner, D. M.; Kroeze, W. K.; Roth, B. L. Evidence for a Model of Agonist-Induced Activation of 5-Hydroxytryptamine 2a Serotonin Receptors That Involves the Disruption of a Strong Ionic Interaction between Helices 3 and 6. J. Biol. Chem. 2002, 277, 11441-11449.
68. Ballesteros, J. A.; Jensen, A. D.; Liapakis, G.; Rasmussen, S. G.; Shi, L.; Gether, U.; Javitch, J. A. Activation of the Beta 2-Adrenergic Receptor Involves Disruption of an Ionic Lock between the Cytoplasmic Ends of Transmembrane Segments 3 and 6. J. Biol. Chem. 2001, 276, 29171-29177.
69. Greasley, P. J.; Fanelli, F.; Rossier, O.; Abuin, L.; Cotecchia, S. Mutagenesis and Modelling of the Alpha(1b)-Adrenergic Receptor Highlight the Role of the Helix 3/Helix 6 Interface in Receptor Activation. Mol. Pharmacol. 2002, 61, 1025-1032.
70. Yao, X.; Parnot, C.; Deupi, X.; Ratnala, V. R.; Swaminath, G.; Farrens, D.; Kobilka, B. Coupling Ligand Structure to Specific Conformational Switches in the Beta2-Adrenoceptor. Nat. Chem. Biol. 2006, 2, 417-422.
71. Moukhametzianov, R.; Warne, T.; Edwards, P. C.; Serrano-Vega, M. J.; Leslie, A. G.; Tate, C. G.; Schertler, G. F. Two Distinct Conformations of Helix 6 Observed in Antagonist-Bound Structures of a Beta1-Adrenergic Receptor. Proc. Natl. Acad. Sci. U. S. A. 2011, 108, 8228-8232.
72. Lebon, G.; Warne, T.; Edwards, P. C.; Bennett, K.; Langmead, C. J.; Leslie, A. G.; Tate, C. G. Agonist-Bound Adenosine A2a Receptor Structures Reveal Common Features of GPCR Activation. Nature 2011, 474, 521-525.
73. Xu, F.; Wu, H.; Katritch, V.; Han, G. W.; Jacobson, K. A.; Gao, Z. G.; Cherezov, V.; Stevens, R. C. Structure of an Agonist-Bound Human A2a Adenosine Receptor. Science 2011, 332, 322-327.
74. Egloff, P.; Hillenbrand, M.; Klenk, C.; Batyuk, A.; Heine, P.; Balada, S.; Schlinkmann, K. M.; Scott, D. J.; Schutz, M.; Pluckthun, A. Structure of Signaling-Competent Neurotensin Receptor 1 Obtained by Directed Evolution in Escherichia Coli. Proc. Natl. Acad. Sci. U. S. A. 2014, 111, E655-662.
75. Burg, J. S.; Ingram, J. R.; Venkatakrishnan, A. J.; Jude, K. M.; Dukkipati, A.; Feinberg, E. N.; Angelini, A.; Waghray, D.; Dror, R. O.; Ploegh, H. L.; et al. Structural Biology. Structural Basis for Chemokine Recognition and Activation of a Viral G Protein-Coupled Receptor. Science 2015, 347, 1113-1117.
76. Strachan, R. T.; Sun, J. P.; Rominger, D. H.; Violin, J. D.; Ahn, S.; Rojas Bie Thomsen, A.; Zhu, X.; Kleist, A.; Costa, T.; Lefkowitz, R. J. Divergent Transducer-Specific Molecular Efficacies Generate Biased Agonism at a G Protein-Coupled Receptor (GPCR). J. Biol. Chem. 2014, 289, 14211-14224.
77. Klein Herenbrink, C.; Sykes, D. A.; Donthamsetti, P.; Canals, M.; Coudrat, T.; Shonberg, J.; Scammells, P. J.; Capuano, B.; Sexton, P. M.; Charlton, S. J.; et al. The Role of Kinetic Context in Apparent Biased Agonism at GPCRs. Nat. Commun. 2016, 7, 10842.
78. Shukla, A. K.; Xiao, K.; Lefkowitz, R. J. Emerging Paradigms of Beta-Arrestin-Dependent Seven Transmembrane Receptor Signaling. Trends Biochem. Sci. 2011, 36, 457-469.
79. Gurevich, V. V.; Gurevich, E. V. Unit 2.10. Overview of Different Mechanisms of Arrestin-Mediated Signaling. Curr. Protoc. Pharmacol. 2014, 67, 2.10.1-2.10.9.
80. Kang, D. S.; Tian, X.; Benovic, J. L. Beta-Arrestins and G Protein-Coupled Receptor Trafficking. Methods Enzymol. 2013, 521, 91-108.
81. Sivertsen, B.; Holliday, N.; Madsen, A. N.; Holst, B. Functionally Biased Signalling Properties of 7TM Receptors-Opportunities for Drug Development for the Ghrelin Receptor. Br. J. Pharmacol. 2013, 170, 1349-1362.
82. Liu, J. J.; Horst, R.; Katritch, V.; Stevens, R. C.; Wuthrich, K. Biased Signaling Pathways in Beta2-Adrenergic Receptor Characterized by 19f-NMR. Science 2012, 335, 1106-1110.
83. Wacker, D.; Wang, C.; Katritch, V.; Han, G. W.; Huang, X. P.; Vardy, E.; McCorvy, J. D.; Jiang, Y.; Chu, M.; Siu, F. Y.; et al. Structural Features for Functional Selectivity at Serotonin Receptors. Science 2013, 340, 615-619.
84. Wang, C.; Jiang, Y.; Ma, J.; Wu, H.; Wacker, D.; Katritch, V.; Han, G. W.; Liu, W.; Huang, X. P.; Vardy, E.; et al. Structural Basis for Molecular Recognition at Serotonin Receptors. Science 2013, 340, 610-614.
85. Kang, Y.; Zhou, X. E.; Gao, X.; He, Y.; Liu, W.; Ishchenko, A.; Barty, A.; White, T. A.; Yefanov, O.; Han, G. W.; et al. Crystal Structure of Rhodopsin Bound to Arrestin by Femtosecond X-Ray Laser. Nature 2015, 523, 561-567.
86. Szczepek, M.; Beyriere, F.; Hofmann, K. P.; Elgeti, M.; Kazmin, R.; Rose, A.; Bartl, F. J.; von Stetten, D.; Heck, M.; Sommer, M. E.; et al. Crystal Structure of a Common GPCR-Binding Interface for G Protein and Arrestin. Nat. Commun. 2014, 5, 4801.
87. Butcher, A. J.; Prihandoko, R.; Kong, K. C.; McWilliams, P.; Edwards, J. M.; Bottrill, A.; Mistry, S.; Tobin, A. B. Differential GProtein-Coupled Receptor Phosphorylation Provides Evidence for a Signaling Bar Code. J. Biol. Chem. 2011, 286, 11506-11518.
88. Nobles, K. N.; Xiao, K.; Ahn, S.; Shukla, A. K.; Lam, C. M.; Rajagopal, S.; Strachan, R. T.; Huang, T. Y.; Bressler, E. A.; Hara, M. R.; et al. Distinct Phosphorylation Sites on the Beta(2)-Adrenergic Receptor Establish a Barcode That Encodes Differential Functions of Beta-Arrestin. Sci. Signaling 2011, 4, ra51.
89. Butcher, A. J.; Hudson, B. D.; Shimpukade, B.; Alvarez-Curto, E.; Prihandoko, R.; Ulven, T.; Milligan, G.; Tobin, A. B. Concomitant Action of Structural Elements and Receptor Phosphorylation Determines Arrestin-3 Interaction with the Free Fatty Acid Receptor FFA4. J. Biol. Chem. 2014, 289, 18451-18465.
90. Inagaki, S.; Ghirlando, R.; Vishnivetskiy, S. A.; Homan, K. T.; White, J. F.; Tesmer, J. J.; Gurevich, V. V.; Grisshammer, R. G Protein-Coupled Receptor Kinase 2 (GRK2) and 5 (GRK5) Exhibit Selective Phosphorylation of the Neurotensin Receptor in Vitro. Biochemistry 2015, 54, 4320-4329.
91. Yang, F.; Yu, X.; Liu, C.; Qu, C. X.; Gong, Z.; Liu, H. D.; Li, F. H.; Wang, H. M.; He, D. F.; Yi, F.; et al. Phospho-Selective Mechanisms of Arrestin Conformations and Functions Revealed by Unnatural Amino Acid Incorporation and (19)F-NMR. Nat. Commun. 2015, 6, 8202.
92. Kim, Y. J.; Hofmann, K. P.; Ernst, O. P.; Scheerer, P.; Choe, H. W.; Sommer, M. E. Crystal Structure of Pre-Activated Arrestin P44. Nature 2013, 497, 142-146.
93. Shukla, A. K.; Manglik, A.; Kruse, A. C.; Xiao, K.; Reis, R. I.; Tseng, W. C.; Staus, D. P.; Hilger, D.; Uysal, S.; Huang, L. Y.; et al. Structure of Active Beta-Arrestin-1 Bound to a G-Protein-Coupled Receptor Phosphopeptide. Nature 2013, 497, 137-141.
94. Nuber, S.; Zabel, U.; Lorenz, K.; Nuber, A.; Milligan, G.; Tobin, A. B.; Lohse, M. J.; Hoffmann, C. Beta-Arrestin Biosensors Reveal a Rapid, Receptor-Dependent Activation/Deactivation Cycle. Nature 2016, 531, 661-664.
95. Lee, M. H.; Appleton, K. M.; Strungs, E. G.; Kwon, J. Y.; Morinelli, T. A.; Peterson, Y. K.; Laporte, S. A.; Luttrell, L. M. The Conformational Signature of Beta-Arrestin2 Predicts Its Trafficking and Signalling Functions. Nature 2016, 531, 665-668.
96. Gentry, P. R.; Sexton, P. M.; Christopoulos, A. Novel Allosteric Modulators of G Protein-Coupled Receptors. J. Biol. Chem. 2015, 290, 19478-19488.
97. Jakubik, J.; Bacakova, L.; El-Fakahany, E. E.; Tucek, S. Positive Cooperativity of Acetylcholine and Other Agonists with Allosteric Ligands on Muscarinic Acetylcholine Receptors. Mol. Pharmacol. 1997, 52, 172-179.
98. Conn, P. J.; Christopoulos, A.; Lindsley, C. W. Allosteric Modulators of GPCRs: A Novel Approach for the Treatment of CNS Disorders. Nat. Rev. Drug Discovery 2009, 8, 41-54.
99. Thal, D. M.; Sun, B.; Feng, D.; Nawaratne, V.; Leach, K.; Felder, C. C.; Bures, M. G.; Evans, D. A.; Weis, W. I.; Bachhawat, P.; et al. Crystal Structures of the M1 and M4Muscarinic Acetylcholine Receptors. Nature 2016, 531, 335-340.
100. Hulme, E. C.; Lu, Z. L.; Bee, M. S. Scanning Mutagenesis Studies of the M1Muscarinic Acetylcholine Receptor. Recept. Channels 2003, 9, 215-228.
101. Matsui, H.; Lazareno, S.; Birdsall, N. J. Probing of the Location of the Allosteric Site on M1 Muscarinic Receptors by Site-Directed Mutagenesis. Mol. Pharmacol. 1995, 47, 88-98.
102. Mohr, K.; Trankle, C.; Holzgrabe, U. Structure/Activity Relationships of M2Muscarinic Allosteric Modulators. Recept. Channels 2003, 9, 229-240.
103. Jazayeri, A.; Dore, A. S.; Lamb, D.; Krishnamurthy, H.; Southall, S. M.; Baig, A. H.; Bortolato, A.; Koglin, M.; Robertson, N. J.; Errey, J. C.; et al. Extra-Helical Binding Site of a Glucagon Receptor Antagonist. Nature 2016, 533, 274-277.
104. Nolte, W. M.; Fortin, J. P.; Stevens, B. D.; Aspnes, G. E.; Griffith, D. A.; Hoth, L. R.; Ruggeri, R. B.; Mathiowetz, A. M.; Limberakis, C.; Hepworth, D.; et al. A Potentiator of Orthosteric Ligand Activity at GLP-1R Acts Via Covalent Modification. Nat. Chem. Biol. 2014, 10, 629-631.
105. Bueno, A. B.; Showalter, A. D.; Wainscott, D. B.; Stutsman, C.; Marin, A.; Ficorilli, J.; Cabrera, O.; Willard, F. S.; Sloop, K. W. Positive Allosteric Modulation of the Glucagon-Like Peptide-1 Receptor by Diverse Electrophiles. J. Biol. Chem. 2016, 291, 10700-10715.
106. Langmead, C. J.; Christopoulos, A. Allosteric Agonists of 7TM Receptors: Expanding the Pharmacological Toolbox. Trends Pharmacol. Sci. 2006, 27, 475-481.
107. Knudsen, L. B.; Kiel, D.; Teng, M.; Behrens, C.; Bhumralkar, D.; Kodra, J. T.; Holst, J. J.; Jeppesen, C. B.; Johnson, M. D.; de Jong, J. C.; et al. Small-Molecule Agonists for the Glucagon-Like Peptide 1 Receptor. Proc. Natl. Acad. Sci. U. S. A. 2007, 104, 937-942.
108. Coopman, K.; Huang, Y.; Johnston, N.; Bradley, S. J.; Wilkinson, G. F.; Willars, G. B. Comparative Effects of the Endogenous Agonist Glucagon-Like Peptide-1 (Glp-1)-(7-36) Amide and the Small-Molecule Ago-Allosteric Agent "Compound 2" at the Glp-1 Receptor. J. Pharmacol. Exp. Ther. 2010, 334, 795-808.
109. Katritch, V.; Fenalti, G.; Abola, E. E.; Roth, B. L.; Cherezov, V.; Stevens, R. C. Allosteric Sodium in Class a GPCR Signaling. Trends Biochem. Sci. 2014, 39, 233-244.
110. Liu, W.; Chun, E.; Thompson, A. A.; Chubukov, P.; Xu, F.; Katritch, V.; Han, G. W.; Roth, C. B.; Heitman, L. H.; AP, I. J.; et al. Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions. Science 2012, 337, 232-236.
111. Gutierrez-de-Teran, H.; Massink, A.; Rodriguez, D.; Liu, W.; Han, G. W.; Joseph, J. S.; Katritch, I.; Heitman, L. H.; Xia, L.; Ijzerman, A. P.; et al. The Role of a Sodium Ion Binding Site in the Allosteric Modulation of the a(2a) Adenosine G Protein-Coupled Receptor. Structure 2013, 21, 2175-2185.
112. Inagaki, S.; Ghirlando, R.; White, J. F.; Gvozdenovic-Jeremic, J.; Northup, J. K.; Grisshammer, R. Modulation of the Interaction between Neurotensin Receptor NTS1 and Gq Protein by Lipid. J. Mol. Biol. 2012, 417, 95-111.
113. Botelho, A. V.; Gibson, N. J.; Thurmond, R. L.; Wang, Y.; Brown, M. F. Conformational Energetics of Rhodopsin Modulated by Nonlamellar-Forming Lipids. Biochemistry 2002, 41, 6354-6368.
114. Soubias, O.; Teague, W. E.; Gawrisch, K. Evidence for Specificity in Lipid-Rhodopsin Interactions. J. Biol. Chem. 2006, 281, 33233-33241.
115. Neale, C.; Herce, H. D.; Pomes, R.; Garcia, A. E. Can Specific Protein-Lipid Interactions Stabilize an Active State of the Beta 2 Adrenergic Receptor? Biophys. J. 2015, 109, 1652-1662.
116. Shoichet, B. K.; Kobilka, B. K. Structure-Based Drug Screening for G-Protein-Coupled Receptors. Trends Pharmacol. Sci. 2012, 33, 268-272.
117. Jazayeri, A.; Dias, J. M.; Marshall, F. H. From G Protein-Coupled Receptor Structure Resolution to Rational Drug Design. J. Biol. Chem. 2015, 290, 19489-19495.
118. Kumari, P.; Ghosh, E.; Shukla, A. K. Emerging Approaches to GPCR Ligand Screening for Drug Discovery. Trends Mol. Med. 2015, 21, 687-701.
119. Rodriguez, D.; Ranganathan, A.; Carlsson, J. Discovery of GPCR Ligands by Molecular Docking Screening: Novel Opportunities Provided by Crystal Structures. Curr. Top. Med. Chem. 2015, 15, 2484-2503.
120. Kooistra, A. J.; Leurs, R.; de Esch, I. J.; de Graaf, C. From Three-Dimensional GPCR Structure to Rational Ligand Discovery. Adv. Exp. Med. Biol. 2014, 796, 129-157.
121. Negri, A.; Rives, M. L.; Caspers, M. J.; Prisinzano, T. E.; Javitch, J. A.; Filizola, M. Discovery of a Novel Selective Kappa-Opioid Receptor Agonist Using Crystal Structure-Based Virtual Screening. J. Chem. Inf. Model. 2013, 53, 521-526.
122. Weiss, D. R.; Ahn, S.; Sassano, M. F.; Kleist, A.; Zhu, X.; Strachan, R.; Roth, B. L.; Lefkowitz, R. J.; Shoichet, B. K. Conformation Guides Molecular Efficacy in Docking Screens of Activated Beta-2 Adrenergic G Protein Coupled Receptor. ACS Chem. Biol. 2013, 8, 1018-1026.
123. Rodriguez, D.; Gao, Z. G.; Moss, S. M.; Jacobson, K. A.; Carlsson, J. Molecular Docking Screening Using Agonist-Bound GPCR Structures: Probing the A2a Adenosine Receptor. J. Chem. Inf. Model. 2015, 55, 550-563.
124. Heptares Therapeutics. http://www.heptares.com/pipeline/, accessed July 20, 2016.
125. Zhukov, A.; Andrews, S. P.; Errey, J. C.; Robertson, N.; Tehan, B.; Mason, J. S.; Marshall, F. H.; Weir, M.; Congreve, M. Biophysical Mapping of the Adenosine A2a Receptor. J. Med. Chem. 2011, 54, 4312-4323.
126. Huang, X. P.; Karpiak, J.; Kroeze, W. K.; Zhu, H.; Chen, X.; Moy, S. S.; Saddoris, K. A.; Nikolova, V. D.; Farrell, M. S.; Wang, S.; et al. Allosteric Ligands for the Pharmacologically Dark Receptors GPR68 and GPR65. Nature 2015, 527, 477-483.
127. Tan, Y. S.; Sledz, P.; Lang, S.; Stubbs, C. J.; Spring, D. R.; Abell, C.; Best, R. B. Using Ligand-Mapping Simulations to Design a Ligand Selectively Targeting a Cryptic Surface Pocket of Polo-Like Kinase 1. Angew. Chem., Int. Ed. 2012, 51, 10078-10081.
128. Wassman, C. D.; Baronio, R.; Demir, O.; Wallentine, B. D.; Chen, C. K.; Hall, L. V.; Salehi, F.; Lin, D. W.; Chung, B. P.; Hatfield, G. W.; et al. Computational Identification of a Transiently Open L1/S3 Pocket for Reactivation of Mutant P53. Nat. Commun. 2013, 4, 1407.
129. Guo, D.; Mulder-Krieger, T.; IJzerman, A. P.; Heitman, L. H. Functional Efficacy of Adenosine a(2)a Receptor Agonists Is Positively Correlated to Their Receptor Residence Time. Br. J. Pharmacol. 2012, 166, 1846-1859.
130. Dror, R. O.; Pan, A. C.; Arlow, D. H.; Borhani, D. W.; Maragakis, P.; Shan, Y.; Xu, H.; Shaw, D. E. Pathway and Mechanism of Drug Binding to G-Protein-Coupled Receptors. Proc. Natl. Acad. Sci. U. S. A. 2011, 108, 13118-13123.
131. Tautermann, C. S.; Kiechle, T.; Seeliger, D.; Diehl, S.; Wex, E.; Banholzer, R.; Gantner, F.; Pieper, M. P.; Casarosa, P. Molecular Basis for the Long Duration of Action and Kinetic Selectivity of Tiotropium for the Muscarinic M3 Receptor. J. Med. Chem. 2013, 56, 8746-8756.
132. Bhattacharya, S.; Vaidehi, N. Computational Mapping of the Conformational Transitions in Agonist Selective Pathways of a GProtein Coupled Receptor. J. Am. Chem. Soc. 2010, 132, 5205-5214.
133. Bahar, I.; Lezon, T. R.; Bakan, A.; Shrivastava, I. H. Normal Mode Analysis of Biomolecular Structures: Functional Mechanisms of Membrane Proteins. Chem. Rev. 2010, 110, 1463-1497.
134. Yang, L.; Yang, D.; de Graaf, C.; Moeller, A.; West, G. M.; Dharmarajan, V.; Wang, C.; Siu, F. Y.; Song, G.; Reedtz-Runge, S.; et al. Conformational States of the Full-Length Glucagon Receptor. Nat. Commun. 2015, 6, 7859.
135. Floquet, N.; M'Kadmi, C.; Perahia, D.; Gagne, D.; Berge, G.; Marie, J.; Baneres, J. L.; Galleyrand, J. C.; Fehrentz, J. A.; Martinez, J. Activation of the Ghrelin Receptor Is Described by a Privileged Collective Motion: A Model for Constitutive and Agonist-Induced Activation of a Sub-Class a G-Protein Coupled Receptor (GPCR). J. Mol. Biol. 2010, 395, 769-784.
136. LeVine, M. V.; Weinstein, H. NbIT-A New Information Theory-Based Analysis of Allosteric Mechanisms Reveals Residues That Underlie Function in the Leucine Transporter LeuT. PLoS Comput. Biol. 2014, 10, e1003603.
137. Kong, Y.; Karplus, M. The Signaling Pathway of Rhodopsin. Structure 2007, 15, 611-623.
138. McClendon, C. L.; Friedland, G.; Mobley, D. L.; Amirkhani, H.; Jacobson, M. P. Quantifying Correlations between Allosteric Sites in Thermodynamic Ensembles. J. Chem. Theory Comput. 2009, 5, 2486-2502.
139. Dror, R. O.; Jensen, M. O.; Borhani, D. W.; Shaw, D. E. Exploring Atomic Resolution Physiology on a Femtosecond to Millisecond Timescale Using Molecular Dynamics Simulations. J. Gen. Physiol. 2010, 135, 555-562.
140. Hertig, S.; Latorraca, N. R.; Dror, R. O. Revealing Atomic-Level Mechanisms of Protein Allostery with Molecular Dynamics Simulations. PLoS Comput. Biol. 2016, 12, e1004746.
141. Van Eps, N.; Preininger, A. M.; Alexander, N.; Kaya, A. I.; Meier, S.; Meiler, J.; Hamm, H. E.; Hubbell, W. L. Interaction of a G Protein with an Activated Receptor Opens the Interdomain Interface in the Alpha Subunit. Proc. Natl. Acad. Sci. U. S. A. 2011, 108, 9420-9424.
142. Preininger, A. M.; Meiler, J.; Hamm, H. E. Conformational Flexibility and Structural Dynamics in GPCR-Mediated G Protein Activation: A Perspective. J. Mol. Biol. 2013, 425, 2288-2298.
143. Dror, R. O.; Mildorf, T. J.; Hilger, D.; Manglik, A.; Borhani, D. W.; Arlow, D. H.; Philippsen, A.; Villanueva, N.; Yang, Z.; Lerch, M. T.; et al. Signal Transduction. Structural Basis for Nucleotide Exchange in Heterotrimeric G Proteins. Science 2015, 348, 1361-1365.
144. Alexander, N. S.; Preininger, A. M.; Kaya, A. I.; Stein, R. A.; Hamm, H. E.; Meiler, J. Energetic Analysis of the Rhodopsin-GProtein Complex Links the Alpha5 Helix to Gdp Release. Nat. Struct. Mol. Biol. 2014, 21, 56-63.
145. Boguth, C. A.; Singh, P.; Huang, C. C.; Tesmer, J. J. Molecular Basis for Activation of G Protein-Coupled Receptor Kinases. EMBO J. 2010, 29, 3249-3259.
146. Scott, J. D.; Pawson, T. Cell Signaling in Space and Time: Where Proteins Come Together and When They're Apart. Science 2009, 326, 1220-1224.
147. Neves, S. R.; Tsokas, P.; Sarkar, A.; Grace, E. A.; Rangamani, P.; Taubenfeld, S. M.; Alberini, C. M.; Schaff, J. C.; Blitzer, R. D.; Moraru, I. I.; et al. Cell Shape and Negative Links in Regulatory Motifs Together Control Spatial Information Flow in Signaling Networks. Cell 2008, 133, 666-680.
148. Inda, C.; Dos Santos Claro, P. A.; Bonfiglio, J. J.; Senin, S. A.; Maccarrone, G.; Turck, C. W.; Silberstein, S. Different cAMP Sources Are Critically Involved in G Protein-Coupled Receptor CRHR1 Signaling. J. Cell Biol. 2016, 214, 181.
149. Vilardaga, J. P.; Jean-Alphonse, F. G.; Gardella, T. J. Endosomal Generation of cAMP in GPCR Signaling. Nat. Chem. Biol. 2014, 10, 700-706.
150. Irannejad, R.; Tomshine, J. C.; Tomshine, J. R.; Chevalier, M.; Mahoney, J. P.; Steyaert, J.; Rasmussen, S. G.; Sunahara, R. K.; El-Samad, H.; Huang, B.; et al. Conformational Biosensors Reveal GPCR Signalling from Endosomes. Nature 2013, 495, 534-538.
151. Tsvetanova, N. G.; von Zastrow, M. Spatial Encoding of cyclic AMP Signaling Specificity by GPCR Endocytosis. Nat. Chem. Biol. 2014, 10, 1061-1065.
152. Calebiro, D.; Rieken, F.; Wagner, J.; Sungkaworn, T.; Zabel, U.; Borzi, A.; Cocucci, E.; Zurn, A.; Lohse, M. J. Single-Molecule Analysis of Fluorescently Labeled G-Protein-Coupled Receptors Reveals Complexes with Distinct Dynamics and Organization. Proc. Natl. Acad. Sci. U. S. A. 2013, 110, 743-748.
153. Pediani, J. D.; Ward, R. J.; Godin, A. G.; Marsango, S.; Milligan, G. Dynamic Regulation of Quaternary Organization of the M1Muscarinic Receptor by Subtype-Selective Antagonist Drugs. J. Biol. Chem. 2016, 291, 13132-13146.
154. Shan, J.; Khelashvili, G.; Mondal, S.; Mehler, E. L.; Weinstein, H. Ligand-Dependent Conformations and Dynamics of the Serotonin 5-Ht(2a) Receptor Determine Its Activation and Membrane-Driven Oligomerization Properties. PLoS Comput. Biol. 2012, 8, e1002473.
155. Lane, J. R.; Donthamsetti, P.; Shonberg, J.; Draper-Joyce, C. J.; Dentry, S.; Michino, M.; Shi, L.; Lopez, L.; Scammells, P. J.; Capuano, B.; et al. A New Mechanism of Allostery in a G Protein-Coupled Receptor Dimer. Nat. Chem. Biol. 2014, 10, 745-752.
156. Guo, W.; Shi, L.; Filizola, M.; Weinstein, H.; Javitch, J. A. Crosstalk in G Protein-Coupled Receptors: Changes at the Transmembrane Homodimer Interface Determine Activation. Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 17495-17500.
157. Haga, K.; Kruse, A. C.; Asada, H.; Yurugi-Kobayashi, T.; Shiroishi, M.; Zhang, C.; Weis, W. I.; Okada, T.; Kobilka, B. K.; Haga, T.; et al. Structure of the Human M2 Muscarinic Acetylcholine Receptor Bound to an Antagonist. Nature 2012, 482, 547-551.
158. Vanni, S.; Neri, M.; Tavernelli, I.; Rothlisberger, U. Observation of "Ionic Lock"Formation in Molecular Dynamics Simulations of Wild-Type Beta 1 and Beta 2 Adrenergic Receptors. Biochemistry 2009, 48, 4789-4797.
159. Manglik, A.; Lin, H.; Aryal, D. K.; McCorvy, J. D.; Dengler, D.; Corder, G.; Levit, A.; Kling, R. C.; Bernat, V.; Hubner, H. Structure-Based Discovery of Opioid Analgesics with Reduced Side Effects. Nature 2016, 537, 185-190.